Description

PNC-27 Peptide for Advanced Membrane Biology and Cellular Signaling Research

PNC-27 Peptide is a synthetic chimeric peptide engineered by combining amino acids 12-26 of the human p53 tumor suppressor protein with a membrane residency peptide (MRP). This unique molecular design enables researchers to investigate membrane-associated HDM-2 interactions independently of endogenous p53 signaling while providing a highly characterized experimental model for membrane biology and peptide pharmacology.

Published laboratory research has explored PNC-27 Peptide in studies examining HDM-2 localization, membrane receptor interactions, peptide-mediated pore formation, cellular membrane permeability, and intracellular signaling. Scientists continue to investigate the molecular mechanisms governing selective membrane interactions, protein binding, cellular stress responses, and downstream signaling pathways using both in vitro and preclinical experimental systems.

Beyond membrane biology, PNC-27 has become an important research reagent in oncology, molecular pharmacology, structural biology, peptide engineering, and protein interaction studies. Its defined amino acid sequence and reproducible physicochemical characteristics make it valuable for universities, biotechnology companies, pharmaceutical laboratories, and life science research institutions investigating protein-protein interactions and membrane-associated signaling.

Each batch is synthesized using rigorous quality-controlled manufacturing procedures, analytically verified for purity and identity, and supplied as a stable lyophilized peptide accompanied by a comprehensive Certificate of Analysis to support reproducible scientific investigations.

For research use only. Not intended for human consumption or clinical use.

Key Research Highlights

• Synthetic 32-amino-acid chimeric peptide
• Contains the HDM-2-binding domain of human p53
• Fused to a membrane residency peptide (MRP)
• Extensively investigated in membrane biology research
• Frequently utilized in HDM-2 interaction studies
• Evaluated in peptide-mediated membrane permeability investigations
• Studied in molecular oncology and protein interaction research
• High-purity lyophilized peptide suitable for laboratory applications
• Certificate of Analysis (COA) supplied with every batch
• Manufactured under stringent analytical quality standards
• Excellent batch-to-batch reproducibility
• Suitable for biotechnology, pharmaceutical, and academic research laboratories

Why Researchers Choose This Product

• ≥99% research-grade purity verified through analytical testing
• Verified 32-amino-acid chimeric peptide sequence
• Stable lyophilized formulation for long-term laboratory storage
• Comprehensive Certificate of Analysis included
• Reliable reproducibility across experimental studies
• Suitable for molecular oncology and membrane biology research
• Manufactured using rigorous peptide synthesis protocols
• Excellent analytical consistency between production batches
• Available in multiple laboratory quantities
• Intended exclusively for scientific laboratory investigations

Research Applications

HDM-2 Protein Interaction Research

PNC-27 Peptide is extensively utilized in laboratory investigations examining interactions between the p53-derived binding domain and membrane-associated HDM-2 protein within experimental cellular systems.

Membrane Biology

Researchers employ PNC-27 to investigate peptide-membrane interactions, membrane protein localization, pore formation mechanisms, membrane permeability, and structural membrane biology.

Molecular Oncology Research

Experimental models utilize PNC-27 to study protein-protein interactions, intracellular signaling pathways, membrane-associated molecular mechanisms, and cellular responses in transformed cell models.

Cellular Signal Transduction

Scientists investigate intracellular signaling networks involving MAPK/ERK, PI3K/Akt, stress-response pathways, apoptosis-associated proteins, and transcriptional regulation following peptide interaction.

Protein Engineering

PNC-27 serves as an experimental model for studying peptide design, fusion peptide engineering, protein domain interactions, and structure-function relationships.

Peptide Pharmacology

Researchers utilize PNC-27 to evaluate peptide stability, molecular transport, analytical characterization, formulation development, and biochemical interaction kinetics.

Product Specifications

Mechanism of Action

PNC-27 Peptide is a synthetic fusion peptide composed of the HDM-2-binding domain of the human tumor suppressor protein p53 (residues 12-26) linked to a membrane residency peptide (MRP). Unlike native p53, which functions primarily as a nuclear transcription factor, PNC-27 is engineered to facilitate investigation of membrane-associated HDM-2 interactions within controlled laboratory environments.

Published laboratory studies indicate that the p53-derived region of PNC-27 retains high affinity for HDM-2 (human double minute-2 protein, MDM2), a key regulator of p53 signaling. Experimental evidence suggests that when HDM-2 is localized at the plasma membrane in certain transformed cell models, PNC-27 binds selectively to membrane-associated HDM-2, providing researchers with an experimental platform for investigating protein localization, receptor accessibility, and membrane-associated signaling mechanisms.

Following membrane association, laboratory investigations have reported peptide-mediated formation of transmembrane pores in selected experimental systems. Researchers continue to study the structural basis of pore assembly, membrane permeability changes, ion flux, and alterations in membrane integrity using biochemical assays, live-cell imaging, and electrophysiological techniques. The precise molecular sequence of pore formation remains an active area of investigation.

Additional studies explore downstream signaling events following HDM-2 interaction, including modulation of intracellular calcium homeostasis, mitochondrial membrane dynamics, oxidative stress responses, stress-activated protein kinases, and protein interaction networks associated with cellular adaptation. Researchers also investigate interactions with MAPK/ERK, PI3K/Akt, and other signaling pathways that regulate cellular communication and membrane-associated molecular processes.

Because of its unique chimeric structure, defined amino acid sequence, and selective HDM-2-binding properties, PNC-27 Peptide remains a valuable experimental reagent for molecular oncology, membrane biology, structural biochemistry, peptide pharmacology, and biotechnology laboratories investigating protein-protein interactions, membrane dynamics, and peptide engineering.

For research use only. Not intended for human consumption or clinical use.